Biosimilars FORUM - 10 years of the regulatory framework in Europe
- Effective and feasible biosimilar clinical programmes
- Clinical immunogenicity testing
- CMC/quality risk management
- Comparability exercise
- Smart extrapolation and interchangeability
- Global trends
We would like to give you a thorough update on the new challenges and opportunities arising in connection with the revised overarching biosimilars guideline and the updated product-specific guidelines.
During the two-day conference you will receive valuable information on comparability exercises, bioequivalence, interchangeability and immunogenicity testing, as well as in-depth information on quality issues.
After having attended this meeting you will be familiar with the current regulatory requirements and will have a first insight into the global trends. You will know about the main development challenges and will have new ideas on how to overcome them (e.g. in designing appropriate studies and analysing programmes).
Termin
| Datum: | 08.07.2015 |
| Ort: | Steigenberger Metropolitan Poststr. 6 -60329 Frankfurt |
| Preis: | 1.890,00 EUR zzgl. MwSt. |
Zielgruppe
This conference addresses the needs of managers in the pharmaceutical industry who work with biosimilars.
Especially those working in the following areas will benefit from this event:
- marketing authorisation
- clinical + preclinical trials
- quality + analytics
- business development + law.
Kontaktinformationen
Weitere Pharma-Seminare, die Sie interessieren könnten:
| 25.04.2024 | Laborplanung mit Lean Lab Design - Webinar |
| 10.10.2024 | Laborplanung mit Lean Lab Design - Webinar |
| 16.05.2024 | Lean Lab – Erfolgreiche Optimierungen im Labor |
| 26.09.2024 | Lean Lab – Erfolgreiche Optimierungen im Labor |
| 13.11.2024 | Lean Management im Labor (1 Tag) |
